PharmAust Ltd (PAA)

0.100
0.000(0.00%)
  • Volume:
    238,116
  • Bid/Ask:
    0.100/0.105
  • Day's Range:
    0.100 - 0.105

PAA Overview

Prev. Close
0.1
Day's Range
0.1-0.105
Revenue
3.45M
Open
0.105
52 wk Range
0.087-0.25
EPS
-0.01
Volume
238,116
Market Cap
33.26M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
391,184
P/E Ratio
-
Beta
1.25
1-Year Change
-44.74%
Shares Outstanding
316,729,920
Next Earnings Date
-
What is your sentiment on PharmAust Ltd?
or
Vote to see community's results!

PharmAust Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralBuyStrong BuySell
Technical IndicatorsSellSellBuyStrong BuySell
SummaryNeutralNeutralBuyStrong BuySell

PharmAust Ltd Company Profile

PharmAust Ltd Company Profile

Employees
0
Market
Australia

PharmAust Limited, a clinical-stage company, develops targeted cancer therapeutics for human and animal healthcare. The company develops drug discovery intellectual property for the treatment of various cancers in humans and animals. Its lead candidate is Monepantel, which are in Phase II clinical trials for the treatment of cancer. The company also provides highly specialized medicinal and synthetic chemistry services on a contract basis to clients to the drug discovery and pharmaceutical industries. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of monepantel (MPL) upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.